創新公司
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership80,651 shares
Latest Disclosed Value $ 1,612,213
Alliancebernstein L.p. reports 21.02% increase in ownership of INVA / Innoviva, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 80,651 shares of Innoviva, Inc. (US:INVA) valued at $1,879,168 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 66,640 shares of Innoviva, Inc.. This represents a change in shares of 21.02% during the quarter. The current value of the position is $1,787,226 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INNOVIVA COM 45781M101 80,651 14,011 21.02 1,612 21.02 0.0004
2026-02-17 2025-12-31 13F INNOVIVA COM 45781M101 66,640 0 0.00 1,332 9.54 0.0004
2025-11-14 2025-09-30 13F INNOVIVA COM 45781M101 66,640 -2,400 -3.48 1,216 -12.33 0.0004
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 69,040 1,300 1.92 1,387 12.95 0.0005
2025-05-15 2025-03-31 13F INNOVIVA COM 45781M101 67,740 0 0.00 1,228 4.51 0.0004
2025-02-12 2024-12-31 13F INNOVIVA COM 45781M101 67,740 0 0.00 1,175 -10.17 0.0004
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 67,740 -3,215 -4.53 1,308 12.47 0.0004
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 70,955 -100 -0.14 1,164 7.49 0.0004
2024-05-14 2024-03-31 13F INNOVIVA COM 45781M101 71,055 55,435 354.90 1,083 1,617.46 0.0004
2024-02-14 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 15,620 0 0.00 63 50.00 0.0000
2024-02-14 2023-12-31 13F INNOVIVA COM 45781M101 91,335 605 1,465 0.0006
2023-11-14 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 15,620 -202,858 -92.85 42 -97.94 0.0000
2023-11-14 2023-09-30 13F INNOVIVA COM 45781M101 90,730 0 1,179 0.0005
2023-08-15 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 218,478 64,161 41.58 2,038 48.76 0.0008
2023-08-15 2023-06-30 13F INNOVIVA COM 45781M101 90,730 29,480 1,155 0.0005
2023-05-15 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 154,317 83,798 118.83 1,370 46.68 0.0006
2023-05-15 2023-03-31 13F INNOVIVA COM 45781M101 61,250 -9,269 689 0.0002
2023-02-15 2022-12-31 13F INNOVIVA COM 45781M101 70,519 66 0.09 934 14.18 0.0004
2022-11-15 2022-09-30 13F INNOVIVA COM 45781M101 70,453 82 0.12 818 -21.27 0.0004
2022-08-15 2022-06-30 13F INNOVIVA COM 45781M101 70,371 6,013 9.34 1,039 -16.55 0.0005
2022-05-13 2022-03-31 13F INNOVIVA COM 45781M101 64,358 -41,592 -39.26 1,245 -31.89 0.0005
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 105,950 -13,772 -11.50 1,828 -8.65 0.0006
2021-11-10 2021-09-30 13F INNOVIVA COM 45781M101 119,722 -6,489 -5.14 2,001 18.26 0.0008
2021-07-30 2021-06-30 13F INNOVIVA COM 45781M101 126,211 0 0.00 1,692 12.20 0.0007
2021-05-06 2021-03-31 13F INNOVIVA COM 45781M101 126,211 -8,487 -6.30 1,508 -9.65 0.0007
2021-02-08 2020-12-31 13F INNOVIVA COM 45781M101 134,698 -81,325 -37.65 1,669 -26.05 0.0008
2020-11-12 2020-09-30 13F INNOVIVA COM 45781M101 216,023 -33,366 -13.38 2,257 -35.26 0.0012
2020-08-13 2020-06-30 13F INNOVIVA COM 45781M101 249,389 7,397 3.06 3,486 22.49 0.0020
2020-05-14 2020-03-31 13F INNOVIVA COM 45781M101 241,992 -5,050 -2.04 2,846 -18.64 0.0020
2020-02-18 2019-12-31 13F INNOVIVA COM 45781M101 247,042 2,600 1.06 3,498 35.79 0.0020
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 244,442 -15,600 -6.00 2,576 -31.96 0.0016
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 260,042 36,200 16.17 3,786 20.53 0.0024
2019-05-14 2019-03-31 13F INNOVIVA COM 45781M101 223,842 -3,360 -1.48 3,141 -20.78 0.0020
2019-02-13 2018-12-31 13F INNOVIVA COM 45781M101 227,202 -44,990 -16.53 3,965 -4.41 0.0029
2018-11-08 2018-09-30 13F INNOVIVA COM 45781M101 272,192 10,180 3.89 4,148 14.71 0.0027
2018-08-13 2018-06-30 13F INNOVIVA COM 45781M101 262,012 17,900 7.33 3,616 -11.13 0.0025
2018-05-14 2018-03-31 13F INNOVIVA COM 45781M101 244,112 -65,760 -21.22 4,069 -7.46 0.0029
2018-02-13 2017-12-31 13F INNOVIVA COM 45781M101 309,872 16,810 5.74 4,397 6.26 0.0031
2017-11-13 2017-09-30 13F INNOVIVA COM 45781M101 293,062 21,370 7.87 4,138 18.98 0.0031
2017-08-10 2017-06-30 13F INNOVIVA COM 45781M101 271,692 122,620 82.26 3,478 68.67 0.0027
2017-05-11 2017-03-31 13F INNOVIVA COM 45781M101 149,072 -3,500 -2.29 2,062 26.27 0.0016
2017-02-13 2016-12-31 13F INNOVIVA COM 45781M101 152,572 0 0.00 1,633 -2.62 0.0014
2016-11-10 2016-09-30 13F INNOVIVA COM 45781M101 152,572 -15 -0.01 1,677 4.36 0.0014
2016-08-11 2016-06-30 13F INNOVIVA COM 45781M101 152,587 6,400 4.38 1,607 -12.66 0.0014
2016-05-13 2016-03-31 13F INNOVIVA COM 45781M101 146,187 0 0.00 1,840 19.40 0.0016
2016-02-16 2015-12-31 13F/A-1 THERAVANCE COM 88338T104 146,187 0 0.00 1,541 46.76 0.0013
2016-02-12 2015-12-31 13F THERAVANCE COM 88338T104 146,187 1,050
2015-11-13 2015-09-30 13F THERAVANCE COM 88338T104 146,187 -156,058 -51.63 1,050 -80.78 0.0009
2015-08-14 2015-06-30 13F THERAVANCE COM 88338T104 302,245 -34,880 -10.35 5,462 3.06 0.0045
2015-05-13 2015-03-31 13F THERAVANCE COM 88338T104 337,125 80,042 31.13 5,300 45.68 0.0043
2015-02-13 2014-12-31 13F THERAVANCE COM 88338T104 257,083 -2,370,779 -90.22 3,638 -91.90 0.0030
2014-11-13 2014-09-30 13F THERAVANCE COM 88338T104 2,627,862 -268,035 -9.26 44,910 -47.92 0.0378
2014-08-13 2014-06-30 13F THERAVANCE COM 88338T104 2,895,897 517,145 21.74 86,240 17.18 0.0727
2014-05-13 2014-03-31 13F THERAVANCE COM 88338T104 2,378,752 2,230,218 1,501.49 73,599 1,289.97 0.0636
2014-02-13 2013-12-31 13F THERAVANCE COM 88338T104 148,534 17,315 13.20 5,295 -1.32 0.0047
2013-11-14 2013-09-30 13F THERAVANCE COM 88338T104 131,219 -4,904 -3.60 5,366 2.31 0.0053
2013-08-13 2013-06-30 13F THERAVANCE COM 88338T104 136,123 136,123 5,245 0.0056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.